Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4084/MJHID.2019.007 http://scihub22266oqcxt.onion/10.4084/MJHID.2019.007 30671213!6328037!30671213     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=30671213&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mediterr+J+Hematol+Infect+Dis 2019 ; 11 (1): e2019007 Nephropedia Template TP {{tp|p=30671213|t=2019. Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance |pdf=|usr=}}{{30671213}} gab.com Text Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance JO: Mediterr J Hematol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=30671213 #FOAvip Monoclonal gammopathy of renal significance (MGRS) defines renal diseases resulting from the nephrotoxic effects of monoclonal proteins secreted from non-malignant clonal B cells or plasma cells, that do not meet criteria for multiple myeloma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, or lymphomas. Renal disease in MGRS can result from monoclonal immunoglobulin deposition to different parts of the kidney and includes a wide spectrum of glomerular, tubulointerstitial and vascular renal diseases. Recognizing MGRS is important because renal outcomes are poor and treatments targeting the underlying clonal disease have been associated with improved renal survival. In this case report, we present a case of a patient with proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) subtype of MGRS who underwent a phased clone directed treatment of induction and extended maintenance therapy to achieve renal response. Twit Text FOAVip Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance ????Mediterr J Hematol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=30671213 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30671213 #FOAvip English Wikipedia <ref>{{Cite pmid|30671213}}</ref> Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance #MMPMID30671213 Lee H; Duggan P; Neri P; Tay J; Jimenez-Zepeda VH Mediterr J Hematol Infect Dis 2019[]; 11 (1): e2019007 PMID30671213show ga Monoclonal gammopathy of renal significance (MGRS) defines renal diseases resulting from the nephrotoxic effects of monoclonal proteins secreted from non-malignant clonal B cells or plasma cells, that do not meet criteria for multiple myeloma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, or lymphomas. Renal disease in MGRS can result from monoclonal immunoglobulin deposition to different parts of the kidney and includes a wide spectrum of glomerular, tubulointerstitial and vascular renal diseases. Recognizing MGRS is important because renal outcomes are poor and treatments targeting the underlying clonal disease have been associated with improved renal survival. In this case report, we present a case of a patient with proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) subtype of MGRS who underwent a phased clone directed treatment of induction and extended maintenance therapy to achieve renal response. ?Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of R(epmc).pdf DeepDyve Pubget Overpricing